Grace & White Inc’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
SAM
GA
AA
OFA
PFS
AIP
ONB
VFM
QCM
Grace & White Inc's NVO Position: Q2 2026 in Review
Grace & White Inc held its Novo Nordisk (NVO) position steady in Q2 2026 at 29,000 shares worth $1.39M. The position accounts for 0.22% of the portfolio, ranked #78.
Grace & White Inc first reported a position in NVO in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.24M in Q1 2024. 240 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Grace & White Inc held 29,000 shares of Novo Nordisk worth $1.39M as of Q2 2026.
- Grace & White Inc left its Novo Nordisk share count unchanged in Q2 2026.
- Novo Nordisk made up 0.22% of Grace & White Inc's portfolio in Q2 2026, its #78 holding.
- Grace & White Inc first reported a position in Novo Nordisk in Q1 2023 and has held it in 14 quarters since.
- Grace & White Inc's Novo Nordisk position peaked at $4.24M in Q1 2024.
- 240 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Grace & White Inc's 13F filing for Q2 2026, filed 17 Jul 2026.